Resistance to Targeted ABC Transporters in Cancer
This volume covers the most current topics relevant to ABC transporters and resistance to novel and established anticancer drugs, prognosis of patients to compounds to modulate multidrug resistance, compounds used in photodynamic therapy, tyrosine kinase inhibitors and others. Furthermore, the poten...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Cham :
Springer International Publishing : Imprint: Springer,
2015.
|
| Σειρά: | Resistance to Targeted Anti-Cancer Therapeutics,
4 |
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Role of P-glycoprotein for resistance of tumors to anticancer drugs: From bench to bedside
- Clinical relevance of multidrug-resistance-related proteins (MRPs) for anticancer drug resistance and prognosis
- Role of Breast Cancer Resistance Protein (BCRP, ABCG2) in Cancer Outcomes and Drug Resistance
- A new strategy of ALA-photodynamic cancer therapy: Inhibition of ABC transporter ABCG2
- ABC transporters in cancer stem-like cells
- Radiopharmaceuticals for the imaging of ABC-transporter-mediated multidrug resistance in cancer
- Modulation of P-glycoprotein-mediated multidrug resistance by synthetic and phytochemical small molecules, monoclonal antibodies and therapeutic nucleic acids
- ABC transporter modulatory drugs from marine sources: A new approach to overcome drug resistance in cancer
- The role of ABC multidrug transporters in resistance to targeted anti-cancer kinase inhibitors
- Nanotechnology to combat multidrug resistance in cancer
- Drugs affecting epigenetic modifications of ABC transporters.
